Recent Finacing
Recent Raise
APIM Therapeutics, a Trondheim NTNU spin‑out, develops PCNA‑targeting peptide therapeutics (lead ATX‑101) that modulate DNA repair/cell cycle and sensitize tumors to existing chemotherapies in preclinical studies.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors